Nurturher Aesthetics points out retatrutide has not been FDA approved and explains why most providers are not taking it themselves.
Recap by typeshit. Post by @nurturher_aesthetics on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Months after an advisory panel backed easing limits on BPC-157 and others, Medical Daily reviews hospitalizations and Nevada fines over two intubated women.
The fitness centre says it knows about reports of peptides being sold or promoted inside the gym and makes clear that isn't allowed.
Loading…